Intravenous ascorbic acid as an adjuvant to interleukin-2 immunotherapy-Reference-Cited by-同舟云学术

Intravenous ascorbic acid as an adjuvant to interleukin-2 immunotherapy

Published:2014 Issue:1 Volume:12 Page:127
ISSN:1479-5876
Container-title:Journal of Translational Medicine
language:en
Short-container-title:Journal of Translational Medicine

Author:

Wagner Samuel C,Markosian Boris,Ajili Naseem,Dolan Brandon R,Kim Andy J,Alexandrescu Doru T,Dasanu Constantin A,Minev Boris,Koropatnick James,Marincola Francesco M,Riordan Neil H

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference68 articles.

1. Coley's toxins, tumor necrosis factor and cancer research: A historical perspective

2. Tumour necrosis factor and cancer

3. Tumor necrosis factor as an antineoplastic agent: pitfalls and promises

4. Clinical studies with TNF

5. T cell growth factor receptors. Quantitation, specificity, and biological relevance

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human Colon Cancer HT29 Cell Line Treatment with High-Dose LAscorbic Acid Results to Reduced Angiogenic Proteins Expression and Elevated Pro-apoptotic Proteins Expression;Current Molecular Medicine;2023-06

2. Embracing cancer immunotherapy with vital micronutrients;World Journal of Clinical Oncology;2021-09-24

3. Long-term stabilization of metastatic melanoma with sodium dichloroacetate;World Journal of Clinical Oncology;2017

4. Ascorbic acid and ascorbate-2-phosphate decrease HIF activity and malignant properties of human melanoma cells;BMC Cancer;2015-11-07

5. Comparison of bacteriolytic activity of human interleukin-2 and chicken egg lysozyme on Lactobacillus plantarum and Escherichia coli cells;Moscow University Chemistry Bulletin;2015-11